Duality Biotherapeutics, Inc.

HK$104.90As of Sun 8 Nov 2026, 12:00 UTC
HKEX:9606Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (65.93%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (66.59%)
Mkt cap HK$9.498B
ROIC (38.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$131
25.03%
(3.06%)
Hold 10|2|11|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.74
1.92
2.05
2.22
10.96%
24.54%
20.95%
36.54%
Revenue¥B
1.057
1.057
1.029
1.084
7.97%
11.03%
3.51%
5.32%
Peers (US$1.212B)
Cap (US$)
PE
1.093B
12.92x
1.214B
—
Capital
TTM
5Y
10Y
Leveragex
0.994
0.030
0.028
EBIT/Intx
0.413
2.516
1.652
Own earn%
(48.18)
(63.09)
(66.77)
Sh yield%
31.08
24.88
25.75
Owners
Insiders/Inst%
10.03
58.44
Short interest%
5.62
SBC / revenue%
2.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
30–35
$1 testx
—
Incr. ROIC%
38